Product details
Origins
The Cannamedical Sativa Strawberry Ice a Sativa dominant hybrid (60%/40%) strain created by crossing the Blueberry strain with an unknown Sativa dominant hybrid. The strain is distinguished by spade-shaped bright green nugs with orange hairs. Strawberry Ice is also famous for its array of sugary sweet strawberry flavours.
Composition
The strain’s cannabinoid composition is made up of 19.4% THC and 1% CBD. It also includes small amounts of other minor cannabinoids.
Cannamedical Sativa Strawberry Ice terpene profile is dominated by Terpinolene and Beta-Caryophyllene. Terpinolene is recognized for its light woody smell combined with floral citrus notes. Recent research is supporting the phenomena of the ‘entourage effect’. This process occurs when a patient consumes a whole plant product like Cannamedical Sativa Strawberry Ice, the cannabinoids and terpenes work together and interact with the endocannabinoid system to improve the overall effect of the product.
Storage
Storing your cannabis product correctly will prolong its life. Keep it in a cool, dry place and away from sunlight. It’s essential to keep this product (and any cannabinoid product) out of the reach of children and animals.
Dosing guidelines
The guidance provided here is not intended to be medical advice – patients will discuss their dosage guidelines with a medical professional independently before beginning their treatment.
Patients who consume this product via inhalation can expect an onset time between 10 to 20 minutes. Consuming cannabis with food and drinks will take longer to feel the effects. However, the duration of action typically lasts between 6 to 10 hours. Also, the onset and the duration times differ for each user depending on their height, weight, body fat percentage, and metabolism.
Cannamedical Sativa Strawberry Ice boasts a medium THC potency, and therefore its use should be monitored and treated with caution.
Lab testing
Cannamedical® Pharma is a renowned provider of high-quality medical cannabis products. The whole manufacturing process meets the highest pharmaceutical quality standards worldwide, known as GMP guidelines. The company is also GDP-certified. Therefore, each batch is tested for its cannabinoid and terpene profiles to ensure that all products have the correct levels of active ingredient. Cannamedical® Pharma does not release products until the independent laboratory has fully approved its chemical composition.
Disclaimer
The information provided in this description is based on its user’s reports and anecdotal research. Further scientific peer-reviewed research and research are needed to verify these claims. Patients should consult their medical doctor before starting treatment for accurate information pertaining to medical cannabis.
